Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Epic Sciences
company
About
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
- 101 - 250
Details
- Last Funding Type
- Series F
- Last Funding Money Raised
- $43M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Hospital
- Founded date
- Jan 1, 2008
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$135M
Epic Sciences has raised a total of
$135M
in funding over 2 rounds. Their latest funding was raised on
Jun 1, 2022 from a Series F round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2022 | Series F | $43M | 1 | — | — | Detail |
| Sep 12, 2018 | Series E | $52M | 1 | — | — | Detail |
| Apr 28, 2017 | Series D | $40M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Epic Sciences is funded by 2 investors.
LabCorp
and Altos Capital Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
LabCorp
|
— | Series F |
|
|
— | Series E |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
